[{"Assets_0_Q1_USD":"1336900000.0","CIK":"899923","CommonStockSharesConverted_0_Q1_shares":"76700000.0","CommonStockSharesOutstanding_0_Q1_shares":"76700000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.52","EarningsPerShareDiluted_1_Q1_USD":"-0.52","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"71800000.0","NetIncomeLossConverted_1_Q1_USD":"-39500000.0","OfficialName":"Myriad Genetics Inc. Common Stock","RevenuesConverted_1_Q1_USD":"173100000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"875200000.0","StockholdersEquity_0_Q1_USD":"875200000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"76000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"76000000.0","filed":"20210505","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"MYRIAD GENETICS INC","period":"20210331","qtrs":"1","uom":"USD"}]